{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:19:07Z","timestamp":1790475547036,"version":"4.1.0"},"reference-count":10,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"569","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.sciencemag.org\/about\/science-licenses-journal-article-reuse"}],"funder":[{"DOI":"10.13039\/100014428","name":"Engelberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017244","name":"Harvard-MIT Center for Regulatory Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017244","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Population Medicine Ebert Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2020,11,11]]},"abstract":"<jats:p>Evaluating the benefits, risks, and costs of two drugs to treat spinal muscular atrophy raises questions about the future of rare disease medicines.<\/jats:p>","DOI":"10.1126\/scitranslmed.aay9648","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:17:41Z","timestamp":1605140261000},"source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and costs of spinal muscular atrophy drugs"],"prefix":"10.1126","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-4243","authenticated-orcid":true,"given":"Jonathan J.","family":"Darrow","sequence":"first","affiliation":[{"name":"Program on Regulation, Therapeutics, and Law, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA 02120, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-0596","authenticated-orcid":true,"given":"Monica","family":"Sharma","sequence":"additional","affiliation":[{"name":"IP-Dhyaan LLP, Dwarka, New Delhi 110075, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-4588","authenticated-orcid":true,"given":"Mansa","family":"Shroff","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-6668","authenticated-orcid":true,"given":"Anita K.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA."},{"name":"Harvard Pilgrim Health Care Inc., Wellesley, MA 02481, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_1_2_2","unstructured":"FDA Medical review for nusinersen (Spinraza) (NDA 209531) 15 December 2016."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70016-8"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180330"},{"key":"e_1_3_1_5_2","unstructured":"FDA Clinical review for onasemnogene abeparvovec-xioi (Zolgensma) (BLA 125694) 23 May 2019."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S172291"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79213"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007527"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1073110517750609"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhpr1713338"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/scitranslmed.aay9648","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.aay9648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:29:25Z","timestamp":1705429765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aay9648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":10,"journal-issue":{"issue":"569","published-print":{"date-parts":[[2020,11,11]]}},"alternative-id":["10.1126\/scitranslmed.aay9648"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.aay9648","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"article-number":"eaay9648"}}